The Oncology Institute, Inc.
TOI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23 | $150 | $120 | $646 |
| - Cash | $50 | $33 | $14 | $114 |
| + Debt | $123 | $120 | $108 | $0 |
| Enterprise Value | $97 | $237 | $214 | $532 |
| Revenue | $393 | $324 | $252 | $203 |
| % Growth | 21.3% | 28.4% | 24.4% | – |
| Gross Profit | $54 | $60 | $52 | $41 |
| % Margin | 13.7% | 18.4% | 20.6% | 20.1% |
| EBITDA | -$54 | -$54 | -$68 | -$42 |
| % Margin | -13.7% | -16.7% | -26.8% | -20.7% |
| Net Income | -$65 | -$83 | $0 | -$11 |
| % Margin | -16.4% | -25.6% | 0.1% | -5.4% |
| EPS Diluted | -0.71 | -0.92 | -0.21 | -0.16 |
| % Growth | 22.8% | -338.1% | -31.2% | – |
| Operating Cash Flow | -$27 | -$36 | -$62 | -$33 |
| Capital Expenditures | -$4 | -$5 | -$6 | -$3 |
| Free Cash Flow | -$30 | -$41 | -$67 | -$36 |